“I would like to take this opportunity to thank your company and of course, also, Thomas White. Thomas has been all the way through very professional, efficient, proactive, pleasant – so overall excellent in supporting me on my latest career move. So this is a 5/5 stars well deserved review!”

Senior Business Development Director – EU, ProtaGene

ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, they provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms.

Their deep history of analytical leadership in protein-based therapeutics stems from the merger of Protagen Protein Services in Europe and BioAnalytix in the US. In 2021, GeneWerk’s unique capabilities in vector safety, integration site analysis, and bioinformatics were added to their portfolio, establishing ProtaGene. Their combined protein- and gene-based analytical platforms make them the leading analytic service provider across the biopharmaceutical and gene and cell therapy development spaces. The organisation operates four sites in Europe and North America and works in advanced therapeutic platforms with leading biopharmaceutical and gene therapy companies worldwide.

Company website – https://www.protagene.com/ 

​To find out more about Resilience, contact Thomas White on +44 (0)20 3854 7700 or thomas.white@mantellassociates.com